Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity

Medical Microbiology and Immunology

Volumn 200, Issue 4, 2011, Pages 209-218

  Pellegrini, Andrea ^a   Carrera Silva, Eugenio Antonio ^a   Arocena, Alfredo ^a   Cano, Roxana Carolina ^a   Aoki, Maria Pilar ^a   Gea, Susana ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Autoimmunity; B cells; IL 4; Survival

Indexed keywords

CRUZIPAIN; FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN G; INTERLEUKIN 4; MYOSIN HEAVY CHAIN; PARASITE ANTIGEN; PROTEIN BCL 2; PROTEIN BCL XL;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOREACTIVITY; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; SURVIVAL RATE; TRYPANOSOMA CRUZI;

ANIMALS; ANTIGENS, CD95; ANTIGENS, PROTOZOAN; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; BCL-X PROTEIN; CARDIAC MYOSINS; CELL SURVIVAL; CHAGAS DISEASE; CYSTEINE ENDOPEPTIDASES; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; IMMUNOGLOBULIN G; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS; TRYPANOSOMA CRUZI; VACCINATION;

EID: 82455222071     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-011-0192-3     Document Type: Article

References (44)

1. Wurster AL, Rodgers VL, White MF, Rothstein TL, Grusby MJ (2002) Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL. J Biol Chem 277:27169-27175
2. Montes CL, Maletto BA, Acosta Rodriguez EV, Gruppi A, Pistoresi-Palencia MC (2006) B cells from aged mice exhibit reduced apoptosis upon B-cell antigen receptor stimulation and differential ability to up-regulate survival signals. Clin Exp Immunol 143:30-40
3. Mizuno T, Zhong X, Rothstein TL (2003) Fas-induced apoptosis in B cells. Apoptosis 8:451-460
4. Cory S, Harris AW, Strasser A (1994) Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells. Philos Trans R Soc Lond B Biol Sci 345:289-295
5. Reed JC (2008) Bcl-2-family proteins and hematologic malignancies: History and future prospects. Blood 111:3322-3330
6. WHO (2002) Control of Chagas disease. Report of a WHO Expert Committee, pp 1-109
7. Girones N, Fresno M (2003) Etiology of Chagas disease myocarditis: Autoimmunity, parasite persistence, or both? Trends Parasitol 19:19-22
8. Gea S, Guinazu N, Pellegrini A, Carrera Silva EA, Giordanengo L, Cano R, Aoki MP (2006) Cruzipain a major Trypanosoma cruzi cystein protease in host-parasite interplay. Inmunología España 25:225-238
9. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV (2007) Pathogenesis of chronic Chagas heart disease. Circulation 115:1109-1123
10. Savino W, Villa-Verde DM, Mendes-da-Cruz DA, Silva-Monteiro E, Perez AR, Aoki Mdel P, Bottasso O, Guinazu N, Silva- Barbosa SD, Gea S (2007) Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi. Cytokine Growth Factor Rev 18:107-1241
11. Leon JS, Godsel LM, Wang K, Engman DM (2001) Cardiac myosin autoimmunity in acute Chagas' heart disease. Infect Immun 69:5643-5649
12. Cazzulo J, Cazzulo Franke M, Martinez J, Franke de Cazzulo B (1990) Some kinetic properties of a cysteine proteinase (cruzipain) from Trypanosoma cruzi. Biochim Biophys Acta 1037:186-191
13. Souto-Padron T, Campetella OE, Cazzulo JJ, de Souza W (1990) Cysteine proteinase in Trypanosoma cruzi: Immunocytochemical localization and involvement in parasite-host cell interaction. J Cell Sci 96(Pt 3):485-490
14. Arnholdt A, Piuvezam M, Russo D, Lima A, Pedrosa R, Reed S, Scharfstein J (1993) Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase. J Immunol 151:3171-3179
15. Laderach D, Cerban F, Motran C, Vottero de Cima E, Gea S (1996) Trypanosoma cruzi: The major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII). Int J Parasitol 26:1249-12541
16. Duschak V, Riarte A, Segura E, Laucella S (2001) Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease. Immunol Lett 78:135-142
17. Giordanengo L, Guinazu N, Stempin C, Fretes R, Cerban F, Gea S (2002) Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur J Immunol 32:1003-1011
18. Guinazu N, Pellegrini A, Giordanengo L, Aoki M, Rivarola H, Cano R, Rodrigues M, Gea S (2004) Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c mice. Microbes Infect 6:1250-1258
19. Pellegrini A, Guinazu N, Aoki MP, Calero IC, Carrera-Silva EA, Girones N, Fresno M, Gea S (2007) Spleen B cells from BALB/c are more prone to activation than spleen B cells from C57BL/6 mice during a secondary immune response to cruzipain. Int Immunol 19:1395-1402
20. Giordanengo L, Maldonado C, Rivarola H, Iosa D, Girones N, Fresno M, Gea S (2000) Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipainimmunized mice and their offspring. Eur J Immunol 30:3181-3189
21. Mongini PK, Inman JK, Han H, Fattah RJ, Abramson SB, Attur M (2006) APRIL and BAFF promote increased viability of replicating human B2 cells via mechanism involving cyclooxygenase 2. J Immunol 176:6736-6751
22. Shiverick KT, Thomas LL, Alpert NR (1975) Purification of cardiac myosin. Application to hypertrophied myocardium. Biochim Biophys Acta 393:124-133
23. Dufort FJ, Bleiman BF, Gumina MR, Blair D, Wagner DJ, Roberts MF, Abu-Amer Y, Chiles TC (2007) Cutting edge: IL-4- mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. J Immunol 179:4953-4957
24. Zhang X, Li L, Choe J, Krajewski S, Reed JC, Thompson C, Choi YS (1996) Up-regulation of Bcl-xL expression protects CD40- activated human B cells from Fas-mediated apoptosis. Cell Immunol 173:149-1541
25. Zheng B, Marinova E, Switzer K, Wansley D, He H, Bheekha- Escura R, Behrens TW, Han S (2007) Overexpression of Bcl(XL) in B cells promotes Th1 response and exacerbates collageninduced arthritis. J Immunol 179:7087-7092
26. Blank M, Shoenfeld Y (2007) B cell targeted therapy in autoimmunity. J Autoimmun 28:62-68
27. Foote LC, Howard RG, Marshak-Rothstein A, Rothstein TL (1996) IL-4 induces Fas resistance in B cells. J Immunol 157:2749-2753
28. Acosta Rodriguez EV, Zuniga E, Montes CL, Gruppi A (2003) Interleukin-4 biases differentiation of B cells from Trypanosoma cruzi-infected mice and restrains their fratricide: Role of Fas ligand down-regulation and MHC class II-transactivator up-regulation. J Leukoc Biol 73:127-136
29. Catlett IM, Bishop GA (1999) Cutting edge: A novel mechanism for rescue of B cells from CD95/Fas-mediated apoptosis. J Immunol 163:2378-2381
30. Tian MT, Chou CH, DeFranco AL (2001) Apoptosis induced by the antigen receptor and Fas in a variant of the immature B cell line WEHI-231 and in splenic immature B cells. Int Immunol 13:581-592
31. Zuniga E, Motran CC, Montes CL, Yagita H, Gruppi A (2002) Trypanosoma cruzi Infection Selectively Renders Parasite- Specific IgG ? B Lymphocytes Susceptible to Fas/Fas Ligand- Mediated Fratricide. J Immunol 168:3965-3973
32. He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, Cerutti A (2004) Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol 172:3268-3279
33. White CA, Nguyen KB, Pender MP (2000) B cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis: Roles of B cell CD95, CD95L and Bcl-2 expression. J Autoimmun 14:195-2041
34. Lopez-Hoyos M, Carrio R, Merino J, Merino R (1998) Regulation of B cell apoptosis by Bcl-2 and Bcl-XL and its role in the development of autoimmune diseases (Review). Int J Mol Med 1:475-483
35. Deming PB, Rathmell JC (2006) Mitochondria, cell death, and B cell tolerance. Curr Dir Autoimmun 9:95-119
36. Schmidt CS, Liu J, Zhang T, Song HY, Sandusky G, Mintze K, Benschop RJ, Glasebrook A, Yang DD, Na S (2003) Enhanced B cell expansion, survival, and humoral responses by targeting death receptor 6. J Exp Med 197:51-62
37. Chu VT, Enghard P, Riemekasten G, Berek C (2007) In vitro and in vivo activation induces BAFF and APRIL expression in B cells. J Immunol 179:5947-5957
38. Moisini I, Davidson A (2009) BAFF: A local and systemic target in autoimmune diseases. Clin Exp Immunol 158:155-163
39. Tangye SG, Bryant VL, Cuss AK, Good KL (2006) BAFF, APRIL and human B cell disorders. Semin Immunol 18:305-317
40. Mackay F, Silveira PA, Brink R (2007) B cells and the BAFF/ APRIL axis: Fast-forward on autoimmunity and signaling. Curr Opin Immunol 19:327-336
41. Kimberley FC, Medema JP, Hahne M (2009) APRIL in B-cell malignancies and autoimmunity. Results Probl Cell Differ 49:161-182
42. Liao L, Sindhwani R, Leinwand L, Diamond B, Factor S (1993) Cardiac alpha-myosin heavy chains differ in their induction of myocarditis. Identification of pathogenic epitopes. J Clin Invest 92:2877-2882
43. Acosta DM, Arnaiz MR, Esteva MI, Barboza M, Stivale D, Orlando UD, Torres S, Laucella SA, Couto AS, Duschak VG (2008) Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice. Int Immunol 20:461-470
44. Shlomchik MJ (2009) Activating systemic autoimmunity: B's, T's, and tolls. Curr Opin Immunol 21:626-633